Optos is debuting the MonacoPro, a next-generation ultra-widefield (UWF) scanning laser ophthalmoscope (SLO) integrating spectral-domain optical coherence tomography (SD-OCT).
Talk about Optos for a moment.
A subsidiary of Nikon Corporation, the retinal imaging company develops integrated UWF high-resolution digital images with image-guided OCT.
Its inventory of UWF retinal imaging devices targets early detection, management, and treatment of ocular conditions such as:
- Glaucoma
- Retinal diseases
- Retinal detachments and tears
- Diabetic retinopathy (DR)
- Age-related macular degeneration (AMD)
To note: While traditional, small-field retinal imaging typically captures 10 to 100° of the retina via a single image—comparatively—all Optos UWF, high-resolution retinal imaging devices are reported to image more than 80% or 200° of the retina in a single capture.
- Learn how an optomap image is captured (and see supporting clinical research validating the company’s UWF retinal imaging).
Now to this new addition.
As an upgrade to the company’s original Monaco imaging platform—initially the only UWF retinal imaging device with integrated SD-OCT—the MonacoPro is designed to advance diagnostic precision and ensure a streamlined workflow for eyecare professionals (ECPs) in clinical practice.
Among its unique capabilities:
- Producing 200° single-shot optomap images in reportedly less than half a second
- Providing cross-sectional 40° OCT views of retinal structures
- Capturing up to five imaging modalities in 90 seconds
Check out a video rundown on it here.
Get into specifics on these imaging modalities and viewing options.
MonacoPro’s optomap imaging modalities include:
- Color rg
- Sensory red-free
- Choroidal
- Green autofluorescence (af)
- SD-OCT
And its image views:
- Standard (the aforementioned 200° single shot)
- Auto-montage (up to 220°)
- Central pole (detailed view of the macula)
- Stereo (imaging pair for optic disc and retinal evaluation)
- OCT (cross-sectional imaging of ocular structures, including fundus)
And these enable …?
According to Optos, the OCT system’s image quality “provides highly detailed and precise retinal images” that enable ECPs to “visualize and analyze retinal layers with greater accuracy.”
Even further: Compared to fundus imaging alone, the MonacoPro is reported to increase macular pathology identification by 29.4% when combined with the integrated 200° single-shot optos imaging.
- See here for technical specifications.
Nice! Now circle back to how this is supposed to help streamline ECPs’ workflow.
That’s thanks to the new AreaAssist tool, which automatically measures (distance and area) color-based retinal areas to provide an objective assessment of change over time.
- How it works: ECPs can simply click and drag selected areas to adjust the sensitivity.
Alongside this is the OptosAdvance Image Management software, which streamlines image review and consultations
Go on …
A major feature: Optos’s comprehensive Reference Database (RDB)—referred to as “one of the largest reference databases in retinal imaging” in the U.S. market.
What it includes: A total of 879 eyes stratified based on optic disc sizes and age.
- Why optic disc size is key: Research presented during last year’s Association for Research in Vision and Ophthalmology (ARVO) meeting reported:
- Strong correlations between optic disc size and optic nerve head (ONH) parameters for identifying relevant patient population data—potentially enabling greater diagnostic precision.
Per Optos: This RDB allows OCT analysis results to be demonstrated in relation to 1%, 5%, 95%, and 99% of the RDB population—a feature that is not available in the previous Monaco system.
Let’s discuss software compliance.
The OCT system also features cybersecurity enhancements that comply with:
- International Organization for Standardization (ISO) guidelines (ISO27032)
- FDA Cybersecurity in Medical Devices requirement for advanced protection from potential threats
Additionally: It includes DICOM-compatible software to support compliance with the U.S. Code of Federal Regulations.
Last question: When will this be available in the United States?
Optos reported the device will start shipping in March 2025.
Click here to request more information.